CID 122267

Efegatran

Structural Information

Molecular Formula
C21H32N6O3
SMILES
CN[C@H](CC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C=O
InChI
InChI=1S/C21H32N6O3/c1-24-17(13-15-7-3-2-4-8-15)20(30)27-12-6-10-18(27)19(29)26-16(14-28)9-5-11-25-21(22)23/h2-4,7-8,14,16-18,24H,5-6,9-13H2,1H3,(H,26,29)(H4,22,23,25)/t16-,17+,18-/m0/s1
InChIKey
KAGLWQUWUNBAOO-KSZLIROESA-N
Compound name
(2S)-N-[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

44
References

2418
Patents

416.2536 Da
Monoisotopic Mass

-0.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 417.26088 200.8
[M+Na]+ 439.24282 198.5
[M-H]- 415.24632 204.9
[M+NH4]+ 434.28742 208.9
[M+K]+ 455.21676 197.0
[M+H-H2O]+ 399.25086 190.1
[M+HCOO]- 461.25180 221.2
[M+CH3COO]- 475.26745 240.2
[M+Na-2H]- 437.22827 196.2
[M]+ 416.25305 195.6
[M]- 416.25415 195.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe